Đang chuẩn bị liên kết để tải về tài liệu:
Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Colorectal cancer is the third most common cancer and a major cause of morbidity and mortality worldwide. Adjuvant chemotherapy is considered the standard of care in patients with UICC stage III colon cancer after R0 resection. |